Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Hart Anastasios JohnDirector |  CRSCARPENTER TECHNOLOGY CORPGrant or award | A | — 193 sh | Oct 8, 2026 |
| 5 | Locke Lori C.Chief Accounting Officer |  WBDWarner Bros. Discovery, Inc.Grant or award | A | — 61.1K sh | Oct 8, 2026 traded Oct 6, 2026 |
| 5 | Hata Yujiro SDirector, President and CEO |  IDYAIDEAYA Biosciences, Inc.Open-market sale · 10b5-1 plan | SELL | $31K 800 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 5 | Younessi RaminDirector | CRSCARPENTER TECHNOLOGY CORP Grant or award | A | — 361 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 5 | Watkins LatrieceExecutive Vice President |  WMTWalmart Inc.Tax withholding | F | $24K 227 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 5 | Aiyar PriyaChief Legal Officer | WBDWarner Bros. Discovery, Inc. Grant or award | A | — 948.7K sh | Oct 8, 2026 traded Oct 6, 2026 |
| 5 | Girdwood AmyChief People & Culture Officer | WBDWarner Bros. Discovery, Inc. Grant or award | A | — 195.5K sh | Oct 8, 2026 traded Oct 6, 2026 |
| 5 | Hart Anastasios JohnDirector | CRSCARPENTER TECHNOLOGY CORP Grant or award | A | — 361 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 5 | Younessi RaminDirector | CRSCARPENTER TECHNOLOGY CORP Grant or award | A | — 193 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 5 | Gryzlov YuryCHIEF OPERATING OFFICER |  GDYNGRID DYNAMICS HOLDINGS, INC.Open-market sale · 10b5-1 plan | SELL | $39K 4,849 sh | Oct 8, 2026 traded Oct 8, 2026 |
| 3 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $15K 499 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 3 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $31K 1,100 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 3 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $27K 901 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 2 | Hata Yujiro SDirector, President and CEO | IDYAIDEAYA Biosciences, Inc. Option exercise · 10b5-1 plan | M | $114K 26.3K sh | Oct 8, 2026 traded Oct 6, 2026 |
| 1 | Hug JoshuaDirector |  RELYRemitly Global, Inc.Open-market sale · 10b5-1 plan | SELL | $127K 5,500 sh | Oct 8, 2026 traded Oct 7, 2026 |
| 1 | Eberwein Jeffrey E.Director, Chief Executive Officer, 10% Owner |  STRRStar Equity Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $9,170 1,000 sh | Oct 8, 2026 traded Oct 8, 2026 |
| 1 | Hug JoshuaDirector | RELYRemitly Global, Inc. Open-market sale · 10b5-1 plan | SELL | $127K 5,500 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 1 | Eberwein Jeffrey E.Director, Chief Executive Officer, 10% Owner | STRRStar Equity Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $9,170 1,000 sh | Oct 8, 2026 traded Oct 7, 2026 |
| 1 | Eberwein Jeffrey E.Director, Chief Executive Officer, 10% Owner | STRRStar Equity Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $9,200 1,000 sh | Oct 8, 2026 traded Oct 6, 2026 |
| 0 | Regnery David SDirector, Chair and CEO |  TTTrane Technologies plcOption exercise · 10b5-1 plan | M | — 48.1K sh | Oct 8, 2026 traded Oct 6, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 8, 2026 traded Oct 7, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 8, 2026 traded Oct 8, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 8, 2026 traded Oct 6, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 8, 2026 traded Oct 8, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 8, 2026 traded Oct 7, 2026 |
| 0 | Haro AlexDirector |  LIFLife360, Inc.Option exercise · 10b5-1 plan | M | $126K 50.0K sh | Oct 8, 2026 traded Oct 6, 2026 |
| 0 | Hata Yujiro SDirector, President and CEO | IDYAIDEAYA Biosciences, Inc. Option exercise · 10b5-1 plan | M | — 26.3K sh | Oct 8, 2026 traded Oct 6, 2026 |
| 0 | Dageville BenoitDirector | SNOWSnowflake Inc. Gift · 10b5-1 plan | G | — 16.7K sh | Oct 8, 2026 traded Oct 7, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 8, 2026 traded Oct 6, 2026 |
| 63 | Barcos Melgar PabloVP INVESTMENT OFFICER |  VTMXVesta Real Estate Corporation, S.A.B. de C.V.Open-market sale | SELL | $22K 6,154 sh | Oct 7, 2026 traded Aug 25, 2026 |
| 49 | Knotnerus Tim JasperDirector, Chief Executive Officer |  AGMBAgomAb Therapeutics NVOpen-market purchase | BUY | $51K 6,000 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 46 | Kemula Pierre Thadee VictorChief Financial Officer | AGMBAgomAb Therapeutics NV Open-market purchase | BUY | $26K 3,000 sh | Oct 7, 2026 traded Oct 6, 2026 |
| 46 | Kemula Pierre Thadee VictorChief Financial Officer | AGMBAgomAb Therapeutics NV Open-market purchase | BUY | $43K 5,000 sh | Oct 7, 2026 traded Oct 6, 2026 |
| 42 | Kemula Pierre Thadee VictorChief Financial Officer | AGMBAgomAb Therapeutics NV Open-market purchase | BUY | $17K 2,000 sh | Oct 7, 2026 traded Oct 6, 2026 |
| 40 | Partridge Andrew JohnChief Growth Officer |  GRALGRAIL, Inc.Open-market sale | SELL | $1.15M 7,873 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 40 | Nilan Nicholas WilliamGeneral Manager-US |  ARQQArqit Quantum Inc.Open-market sale | SELL | $12K 522 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 40 | Freidin AaronChief Financial Officer | GRALGRAIL, Inc. Open-market sale | SELL | $3.46M 23.6K sh | Oct 7, 2026 traded Oct 5, 2026 |
| 40 | Brockman IvanDirector |  VRAVera Bradley, Inc.Open-market purchase | BUY | $50K 10.0K sh | Oct 7, 2026 traded Oct 6, 2026 |
| 38 | Partners Group Private Equity II, LLCAffiliate of the Adviser | NAPartners Group Private Equity Fund, LLC Open-market sale | SELL | $29.96M 13.62M sh | Oct 7, 2026 traded Oct 1, 2026 |
| 38 | Knotnerus Tim JasperDirector, Chief Executive Officer | AGMBAgomAb Therapeutics NV Open-market purchase | BUY | $44K 5,000 sh | Oct 7, 2026 traded Oct 6, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01MARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K